Sinew Pharma Inc. (TPEX:6634)
Taiwan · Delayed Price · Currency is TWD 60.00
0.00 (0.00%)
Aug 19, 2026, 9:52 AM CST
Sinew Pharma Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.05 | 0.05 | - | - | 0.33 | 6.23 | |
Revenue Growth | - | - | - | - | -94.73% | 1248.27% |
Cost of Revenue | 0.01 | 0.01 | - | - | 0.04 | 1.14 |
Gross Profit | 0.04 | 0.04 | - | - | 0.29 | 5.09 |
Selling, General & Admin | 40.72 | 42.69 | 36.95 | 34.75 | 34.1 | 26.77 |
Research & Development | 92.39 | 97.47 | 131.91 | 151.51 | 114.62 | 72.75 |
Operating Expenses | 133.11 | 140.16 | 168.86 | 186.25 | 148.72 | 99.51 |
Operating Income | -133.08 | -140.13 | -168.86 | -186.25 | -148.43 | -94.42 |
Interest Expense | -1.12 | -0.66 | -0.41 | -0.78 | -0.28 | -0.15 |
Interest & Investment Income | 15.73 | 16.19 | 16.66 | 16.03 | 8.37 | 2.95 |
Other Non Operating Income (Expenses) | 0.04 | 0.85 | 2.25 | 0.08 | 0.15 | 0.04 |
Pretax Income | -118.43 | -123.75 | -150.37 | -170.92 | -140.18 | -91.58 |
Net Income | -118.43 | -123.75 | -150.37 | -170.92 | -140.18 | -91.58 |
Net Income to Common | -118.43 | -123.75 | -150.37 | -170.92 | -140.18 | -91.58 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 71 | 71 | 71 | 70 | 69 | 59 |
Shares Outstanding (Diluted) | 71 | 71 | 71 | 70 | 69 | 59 |
Shares Change | 0.08% | -0.37% | 1.21% | 1.68% | 16.47% | 19.41% |
EPS (Basic) | -1.66 | -1.74 | -2.11 | -2.43 | -2.02 | -1.54 |
EPS (Diluted) | -1.66 | -1.74 | -2.11 | -2.43 | -2.02 | -1.54 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -98.33 | -95.93 | -106.26 | -125.26 | -98.99 | -59.5 |
Free Cash Flow Per Share | -1.38 | -1.35 | -1.49 | -1.78 | -1.43 | -1.00 |
Gross Margin | 78.72% | 78.72% | - | - | 88.41% | 81.75% |
Operating Margin | -283142.55% | -298140.43% | - | - | -45252.44% | -1515.81% |
Profit Margin | -251980.85% | -263287.23% | - | - | -42737.81% | -1470.14% |
Free Cash Flow Margin | -209212.77% | -204112.77% | - | - | -30178.66% | -955.19% |
EBITDA | -127.81 | -127.14 | -144.98 | -163.63 | -128.29 | -73.88 |
D&A For EBITDA | 5.26 | 12.99 | 23.88 | 22.62 | 20.13 | 20.55 |
EBIT | -133.08 | -140.13 | -168.86 | -186.25 | -148.43 | -94.42 |